EBR Systems Past Earnings Performance

Past criteria checks 0/6

EBR Systems's earnings have been declining at an average annual rate of -8.7%, while the Medical Equipment industry saw earnings growing at 8.3% annually. Revenues have been declining at an average rate of 158.5% per year.

Key information

-8.7%

Earnings growth rate

74.5%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate-158.5%
Return on equity-131.3%
Net Marginn/a
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

EBR Systems, Inc.'s (ASX:EBR) Intrinsic Value Is Potentially 31% Above Its Share Price

Aug 07
EBR Systems, Inc.'s (ASX:EBR) Intrinsic Value Is Potentially 31% Above Its Share Price

Is EBR Systems, Inc. (ASX:EBR) Worth AU$1.0 Based On Its Intrinsic Value?

Apr 29
Is EBR Systems, Inc. (ASX:EBR) Worth AU$1.0 Based On Its Intrinsic Value?

Is EBR Systems (ASX:EBR) Using Debt In A Risky Way?

Mar 14
Is EBR Systems (ASX:EBR) Using Debt In A Risky Way?

Revenue & Expenses Breakdown

How EBR Systems makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:EBR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240-411722
30 Jun 240-401623
31 Mar 240-381522
31 Dec 230-351421
30 Sep 230-33825
30 Jun 230-331023
31 Mar 230-331222
31 Dec 220-331421
30 Sep 220-361318
30 Jun 220-401316
31 Mar 220-401115
31 Dec 210-401013
30 Sep 210-33911
30 Jun 210-25710
31 Mar 210-26712
31 Dec 200-26713
31 Dec 191-25911

Quality Earnings: EBR is currently unprofitable.

Growing Profit Margin: EBR is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EBR is unprofitable, and losses have increased over the past 5 years at a rate of 8.7% per year.

Accelerating Growth: Unable to compare EBR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EBR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (18.7%).


Return on Equity

High ROE: EBR has a negative Return on Equity (-131.29%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 16:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

EBR Systems, Inc. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
John HesterBell Potter
Martyn JacobsBell Potter